Literature DB >> 16918127

Early post-operative MRI: correlation with progression-free survival and overall survival time in malignant gliomas.

A Vidiri1, C M Carapella, A Pace, A Mirri, A Fabi, M Carosi, D Giannarelli, A Pompili, B Jandolo, E Occhipinti, S Di Giovanni, M Crecco.   

Abstract

Forty-seven patients with Glioblastoma (42) and Anaplastic Astrocytoma (5) were studied with MR 24 hrs after surgery. In order to evaluate the role of early MR in defining the extent of surgical resection and its relation with the prognosis of malignant glioma patients, three categories of surgical resection were considered: gross total, sub-total and partial resection. The results were correlated with progression-free survival (PFS) and overall survival (ST). As demonstrated by early-MR, gross total resection was performed in 17 patients, sub-total and partial resection in 19 and 11 patients, respectively. The PFS was 6 months in gross total resection, 6 and 3 months in sub-total and in partial resection, respectively. The median survival time was 16 months in total resection patients, 13 months and 7 months in sub-total resection and partial resection patients, respectively. The study confirms that early-MR has to be considered an accurate technique for monitoring the extension of malignant glioma surgical resection and shows a good correlation between early-MR findings, PFS and ST.

Entities:  

Mesh:

Year:  2006        PMID: 16918127

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  6 in total

1.  Early post-operative magnetic resonance imaging in glioblastoma: correlation among radiological findings and overall survival in 60 patients.

Authors:  Carles Majós; Mònica Cos; Sara Castañer; Miguel Gil; Gerard Plans; Anna Lucas; Jordi Bruna; Carles Aguilera
Journal:  Eur Radiol       Date:  2015-07-19       Impact factor: 5.315

2.  Immediate post-operative MRI suggestive of the site and timing of glioblastoma recurrence after gross total resection: a retrospective longitudinal preliminary study.

Authors:  Thibault Smets; Tévi Morel Lawson; Cécile Grandin; Aleksandar Jankovski; Christian Raftopoulos
Journal:  Eur Radiol       Date:  2013-01-12       Impact factor: 5.315

Review 3.  Evidence and context of use for contrast enhancement as a surrogate of disease burden and treatment response in malignant glioma.

Authors:  Benjamin M Ellingson; Patrick Y Wen; Timothy F Cloughesy
Journal:  Neuro Oncol       Date:  2018-03-27       Impact factor: 12.300

4.  "Extraoperative" MRI (eoMRI) for Brain Tumor Surgery: Initial Results at a Single Institution.

Authors:  Muhammad M Abd-El-Barr; Seth M Santos; Linda S Aglio; Geoffrey S Young; Srinivasan Mukundan; Alexandra J Golby; William B Gormley; Ian F Dunn
Journal:  World Neurosurg       Date:  2015-02-17       Impact factor: 2.104

5.  The comprehensive neuro-oncology data repository (CONDR): a research infrastructure to develop and validate imaging biomarkers.

Authors:  Sarah Jost Fouke; Tammie L Benzinger; Mikhail Milchenko; Pamela LaMontagne; Joshua S Shimony; Michael R Chicoine; Keith M Rich; Albert H Kim; Eric C Leuthardt; Bart Keogh; Daniel S Marcus
Journal:  Neurosurgery       Date:  2014-01       Impact factor: 4.654

6.  Prediction of Response to Concurrent Chemoradiotherapy with Temozolomide in Glioblastoma: Application of Immediate Post-Operative Dynamic Susceptibility Contrast and Diffusion-Weighted MR Imaging.

Authors:  Eun Kyoung Lee; Seung Hong Choi; Tae Jin Yun; Koung Mi Kang; Tae Min Kim; Se-Hoon Lee; Chul-Kee Park; Sung-Hye Park; Il Han Kim
Journal:  Korean J Radiol       Date:  2015-10-26       Impact factor: 3.500

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.